The analysis of BC samples, accompanied by experimental analysis in vitro and in vivo, described a novel HER2 subtype-specific lincRNA BCLIN25 that promotes mammary carcinogenesis by upregulation of ERBB2 expression via enhancing promoter CpG methylation of miR-125b. The gene discussed is ERBB2; the disease is breast cancer.